MESO
MESOBLAST LT-ADR
Health Care·Biotechnology·AUSTRALIA
$13.19
MCap —
as of 2026-06-26
Total
E1w
Fund
E1w
Quant
D1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-06-27
MIDOS SI
-1.07
Sentiment 90.5%— long zone
−3 oversold0+3 overbought
Signal
BEARISH
Actual
$13.19
Adaptive Mean
$14.35
-1.16 vs mean
Adaptive σ
0.54
MIDOS BB
$13.26 – $15.43
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-05-15
Composite Z
-0.01
ROE
-19.0%
Z -0.08
Rev Gr
—
Z —
EPS Gr
—
Z —
OPM Gr
—
Z —
FCF Yld
—
Z —
EPS Surp
16.1%
Z +0.07
EPS 3mo Δ
—
Z —
Fwd P/E
-204.00
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-06-27
Q3M
-9.75
Q6M
-7.09
Q12M
1.16
MA 30/100
0.954
Bearish (MA30 < MA100)
α (Jensen)
-0.9887
β (12M)
1.54
σ (12M)
0.642
Divergence — Fundamentals vs Momentum
Z Percentile
47%
Q Percentile
49%
Divergence
-1.5
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
-37.6
RS Pctl
11%
RS Decile
D2
Persistence
1w
at grade E
Options / OI Analysis
No options or Williams data available for this ticker.